The number of projects developing advanced nuclear technologies across North America has grown more than 50%, from 48 to 75, over just the past three years, according to a new analysis and interactive map being released today by the centrist think tank Third Way.

Expand chart
Data: Third Way; Chart: Chris Canipe

Why it matters: The trend provides a counterweight to the dismal outlook for America’s existing nuclear industry, which features different technologies and is struggling to remain competitive with cheap natural gas and renewable power.

Quoted: “That growth reflects a combination of interesting technological and business approaches to advanced nuclear, a belief that there’s demand for this technology, and continued efforts by the U.S. Government to support innovation,” said Josh Freed, vice president for clean energy at Third Way.

One level deeper: The Trump administration backs nuclear power, and the technology is also important in addressing climate change because it doesn’t emit any carbon. America’s current fleet of nuclear plants provide roughly 60% of the country’s carbon-free electricity. The projects mapped are at various stages of development, with at least five companies working with federal regulators on the safety licensing process.

Yes, but: The obstacles facing a potential rush of new advanced nuclear reactors are aplenty:

  1. The Energy Department’s budget proposal cuts spending to its nuclear office.
  2. There’s no price on carbon emissions that would monetize nuclear's carbon-free profile.
  3. America’s stagnant electricity growth doesn't provide a lot of room for new power sources.
  4. The aforementioned competition from natural gas and renewables is a challenge for any new electricity source.

Go deeper

Updated 23 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 11:30 p.m. ET: 31,478,387 — Total deaths: 968,726 Total recoveries: 21,622,862Map.
  2. U.S.: Total confirmed cases as of 11:30 p.m. ET: 6,895,685 — Total deaths: 200,768 — Total recoveries: 2,646,959 — Total tests: 96,612,436Map.
  3. Health: The U.S. reaches 200,000 coronavirus deaths — The CDC's crumbling reputation — America turns against coronavirus vaccine.
  4. Politics: Elected officials are failing us on much-needed stimulus.
  5. Business: Two-thirds of business leaders think pandemic will lead to permanent changes — Fed chair warns economy will feel the weight of expired stimulus.
  6. Sports: NFL fines maskless coaches.

Trump pushes to expand ban against anti-racism training to federal contractors

Trump speaking at Moon Township, Penns., on Sept. 22. Photo: Mandel Ngan/AFP via Getty Images

President Trump announced late Tuesday that the White House attempt to halt federal agencies' anti-racism training would be expanded to block federal contractors from "promoting radical ideologies that divide Americans by race or sex."

Why it matters: The executive order appears to give the government the ability to cancel contracts if anti-racist or diversity trainings focused on sexual identity or gender are organized. The memo applies to executive departments and agencies, the U.S. military, federal contractors and federal grant recipients.

Dan Primack, author of Pro Rata
4 hours ago - Economy & Business

GoodRx prices IPO at $33 per share, valued at $12.7 billion

Illustration: Sarah Grillo/Axios

GoodRx, a price comparison app for prescription drugs at local pharmacies, on Tuesday night raised $1.14 billion in its IPO, Axios has learned.

By the numbers: GoodRx priced its shares at $33 a piece, above its $24-$28 per share offering range, which will give it an initial market cap of around $12.7 billion.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!